Alexander Porto
Physician Assistant · Sacramento, CANPI 1912307158
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $916 and has fallen 81.4% since, to $170 in 2025.
Across 137 payments — averaging $20.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$422
- Novo Nordisk$405
- Lilly USA, LLC$398
- Bayer$337
- Biohaven Pharmaceuticals, Inc.$270
- Dexcom, Inc.$164
- plus $812 from 16 others
What the payments were for
- Food & beverage$2,77699%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 23 | $422 |
| Novo Nordisk | 22 | $405 |
| Lilly USA, LLC | 16 | $398 |
| Bayer | 18 | $337 |
| Biohaven Pharmaceuticals, Inc. | 8 | $270 |
| Dexcom, Inc. | 6 | $164 |
| Novartis | 5 | $92 |
| Scilex Pharmaceuticals Inc. | 5 | $86 |
| AstraZeneca | 4 | $83 |
| Merck | 4 | $65 |
| Abbott | 3 | $60 |
| GSK | 3 | $60 |
| Johnson & Johnson | 3 | $56 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $56 |
| Redhill Biopharma Inc. | 2 | $47 |
| Amgen | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 3 | $43 |
| Pfizer | 2 | $33 |
| Organon | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRULICITY$125
- NURTEC ODT$122
How this compares
$2,809 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 27 | $36,695 |
| TrulicityDulaglutide | 22 | $31,602 |
| OzempicSemaglutide | 21 | $25,617 |
| JardianceEmpagliflozin | 46 | $25,077 |
| EliquisApixaban | 30 | $23,030 |
| Dexlansoprazole DrDexlansoprazole | 23 | $4,536 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 97 | $3,002 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,601 |
| Atorvastatin Calcium | 164 | $1,671 |
| Gabapentin | 60 | $1,503 |
| Sucralfate | 21 | $901 |
| Pregabalin | 21 | $747 |
| Rosuvastatin Calcium | 36 | $712 |
| Metformin Hcl | 66 | $668 |
| Lisinopril | 113 | $543 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $405 | $62,31248 claims |
| Lilly USA, LLCTrulicity | $398 | $31,60222 claims |
| Boehringer IngelheimJardiance | $422 | $25,07746 claims |
| PfizerEliquis | $33 | $23,03030 claims |
| AstraZenecaSymbicort | $83 | $2,60112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Sacramento
- Franklin ClineSacramento$458K
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Andrea FoxStanford$172K
- Asma HussainiThousand Oaks$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.